NCT04470648

COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 179 (actual)
• Sponsor: Institut National de la Santé Et de la Recherche Médicale, France · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Study of COVID-19 seroprevalence in precarious population living in shelters of Samusocial de Paris and in staff working in these centers during COVID-19 epidemic.

Detailed description

After emergence of a new coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2) responsible for a cluster of respiratory infection at Wuhan, China, on January, 7th 2020, first cases were diagnosed in France in January 24th 2020. Health care components of Samusocial de Paris (Lits Haltes Soins Santé (LHSS)) were created in 2006. They provide medical care for homeless people and people in social distress not needing an hospitalization. Sometimes there are 3 persons in a bedroom. In december 2018, a special shelter for isolated women or women in precarious situations opened. Because of the living conditions in these centers and the difficulty for these populations to respect social distancing and hygiene recommendations. A first case of COVID-19 was identified on March 8th 2020 in one of these healthcare centers. Other cases were detected in the same center, then in another center on March 16th, then in the dormitory of the women shelter on March 30th. A recent study showed an important prevalence of SARS-COV2 in residents of a homeless shelter in Boston (36%), most of them were asymptomatic. Seroprevalence studies are done in general population or in health care workers, but don't include vulnerable people. It seemed important to us to describe the epidemic in these centers and to study COVID-19 seroprevalence in these particular populations.

Conditions

• SARS-COV2 Infection

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	blood test for SARS-COV2 serology	each person who will accept to participate will have a bood test for a SARS-COV2 serology

Timeline

• Start date: 2020-07-22
• Primary completion: 2021-04-08
• Completion: 2021-08-22
• First posted: 2020-07-14
• Last updated: 2026-01-26

Locations

3 sites across 1 country: France